CONTACT
DIAGNOSTICS
ABOUT ABBOTT
i-STAT Registration
i-STAT Login
CUSTOMER HOME
PARTNERS HOME
DISTRIBUTION HOME
EMPLOYEES HOME
REPAIR MANUAL
COMPLETE PROFILE
DASHBOARD
My Account
United States

Global Point of Care

Panbio™ COVID-19 IgG Rapid Test Device

Detects SARS-CoV-2 IgG antibodies to the S1-RBD protein in as little as 10 minutes with a simple fingerstick

The Panbio™ COVID-19 IgG Rapid Test Device detects immunoglobulin (IgG) antibodies to the SARS-CoV-2 spike protein receptor binding domain (S1-RBD). This test can identify individuals with prior COVID-19 infection or post vaccination antibodies.

This antibody test can help you:

  • Determine if an individual has developed antibodies post infection and/or post vaccination.
  • Conduct serological surveillance. This is done by taking “snapshots” of the percentage of people who have antibodies against SARS-CoV-2 (also called the seroprevalence) at different time points. This can provide information about antibody trends and help professionals determine the burden of severe disease on the healthcare system.1,2 

Product not available in all countries.

Panbio COVID-19 IgG Panbio COVID-19 IgG Panbio COVID-19 IgG
Chapter Navigation
Benefits

Accurate

Robust clinical performance with actual fingerstick whole blood for post infection and post vaccination samples*
21 - 180 days post onset of symptoms
   96.7% Sensitivity (PPA)
   97.0% Specificity (NPA)
≥  30 days after second vaccine dose**
   98.4% Sensitivity (PPA)
   97.0% Specificity (NPA)

*Prospective fingerstick sample study
** Vaccinated subjects were enrolled 30 days or more after their second dose of the BNT162b2 vaccine (Pfizer-BioNTech) or of the mRNA-1273 vaccine (Moderna).

Fast

  • Positive results in as little as 10 minutes
  • Negative results confirmed in 20 minutes

Easy to use

Simple fingerstick test procedure with easy visually-read results interpretation.

Panbio COVID-19 IgG Panbio COVID-19 IgG Panbio COVID-19 IgG
Helpful Documents

SPECIFICATIONS

  • The Panbio COVID-19 IgG Rapid Test Device Kit contains:
    • 25 Test devices individually foil pouched
    • 1 Buffer (3 mL/vial)
    • 25 Specimen droppers (for fingerstick whole blood)
    • 25 Lancets (for fingerstick whole blood)
    • 25 Plasters
    • 26 Alcohol pads
    • Instructions for Use with Quick Reference Guide
  • The Panbio COVID-19 IgG Control Kit should be stored at 2°–8°C.
  • The external controls in the Panbio™ COVID-19 IgG Control Kit are buffer-based reagents specifically formulated and manufactured to ensure performance of the Panbio™ COVID-19 IgG Rapid Test Device and are used to verify the user’s ability to properly perform the test and interpret the results. The positive control will produce a positive test result and has been manufactured to produce a visible test (T) line. The negative control will produce a negative test result. 

PRODUCT CODE

ProductCode
Panbio™ COVID-19 IgG Rapid Test Device (25 Assay Kit)ICO-40206
Panbio™ COVID-19 IgG Control KitCPK-033

References

1. Centers for Disease Control and Prevention. Using Antibody Tests for COVID-19. Updated 10 September 2021. Accessed 09 February 2022. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests.html

2. Centers for Disease Control and Prevention. COVID-19 Serology Surveillance Strategy. Updated 12 February 2021. Accessed 02 February 2022. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/serology-surveillance/index.html 

A Leader In Rapid Point-of-care Diagnostics.

PRODUCT CATALOG
SOLUTIONS
CUSTOMER STORIES
VIEWPOINTS
TOXICOLOGY
CONTACT US
PRODUCT DOCUMENT SEARCH
PRODUCT DEMOS
INTEREST-BASED ADS
CONSUMER HEALTH DATA PRIVACY POLICY

©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.